2026 Regular Session
SB778
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Establishing a clinical research pharmacy permit; authorizing the State Board of Pharmacy to issue a clinical research pharmacy permit; authorizing a health care provider to hold an ownership interest in a clinical research pharmacy under certain circumstances; prohibiting an individual from being required to obtain a license, certification, or authorization to practice under certain provisions of law to own or have an ownership interest in a clinical research pharmacy; etc.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
2 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
March 20, 2026 · Senate
Third Reading Passed
Passed ⭐ Substantive final action
42 yea–0 nay · 1 not voting · 4 absent
April 13, 2026 · House
Third Reading Passed
Passed ⭐ Substantive final action
129 yea–6 nay · 5 not voting · 1 absent
Committee referrals
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
Senate Approved by the Governor - Chapter 206
-
Senate Returned Passed
-
House Third Reading Passed (129-6) View roll call
-
House Favorable Adopted Second Reading Passed
-
House Favorable Report by Health
-
House Hearing 4/02 at 1:00 p.m.
-
House Referred Health
-
Senate Third Reading Passed (42-0) View roll call
-
Senate Second Reading Passed with Amendments
-
Senate Favorable with Amendments {993324/1 Adopted
-
Senate Favorable with Amendments Report by Finance
-
Senate Hearing 3/03 at 1:00 p.m.
-
Senate First Reading Finance